Literature DB >> 18787978

Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity.

Karen Regina Carim da Costa1, Joseane Cristina Ferreira, Marilena Chinali Komesu, Regina Celia Candido.   

Abstract

Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and proteinase) and antifungal drug sensitivity (amphotericin B, fluconazole and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute. The number of colony forming units per milliliter varied according to the Candida species involved and whether a single or mixed infection was present. Proteinase activity was observed in both C. albicans and C. tropicalis, but phospholipase activity was noted only in C. albicans. In vitro resistance to antifungals was verified in both species, but C. tropicalis appears to be more resistant to the tested antifungals than C. albicans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787978     DOI: 10.1007/s11046-008-9154-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  22 in total

Review 1.  Oral candidosis.

Authors:  C S Farah; R B Ashman; S J Challacombe
Journal:  Clin Dermatol       Date:  2000 Sep-Oct       Impact factor: 3.541

2.  Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults.

Authors:  Sukru Oksuz; Idris Sahin; Mustafa Yildirim; Aynur Gulcan; Tevfik Yavuz; Demet Kaya; Ayse Nedret Koc
Journal:  Jpn J Infect Dis       Date:  2007-09       Impact factor: 1.362

Review 3.  Amphotericin B: spectrum and resistance.

Authors:  David Ellis
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

4.  Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 5.  Aspartyl proteinases of Candida albicans and their role in pathogenicity.

Authors:  F De Bernardis; P A Sullivan; A Cassone
Journal:  Med Mycol       Date:  2001-08       Impact factor: 4.076

6.  In vitro susceptibility of oral Candida to seven antifungal agents.

Authors:  T Kuriyama; D W Williams; J Bagg; W A Coulter; D Ready; M A O Lewis
Journal:  Oral Microbiol Immunol       Date:  2005-12

7.  Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains.

Authors:  A Serda Kantarcioglu; A Yücel
Journal:  Mycoses       Date:  2002-06       Impact factor: 4.377

8.  Plate method for detection of phospholipase activity in Candida albicans.

Authors:  M F Price; I D Wilkinson; L O Gentry
Journal:  Sabouraudia       Date:  1982-03

9.  A comparison of secretory proteinases from different strains of Candida albicans.

Authors:  R Rüchel; R Tegeler; M Trost
Journal:  Sabouraudia       Date:  1982-09

10.  Oral candidosis in patients with removable dentures.

Authors:  N S Dar-Odeh; A A Shehabi
Journal:  Mycoses       Date:  2003-06       Impact factor: 4.377

View more
  10 in total

1.  Enzymatic activity, sensitivity to antifungal drugs and Baccharis dracunculifolia essential oil by Candida strains isolated from the oral cavities of breastfeeding infants and in their mothers' mouths and nipples.

Authors:  Cristiane Aparecida Pereira; Anna Carolina Borges Pereira da Costa; Ana Karina Silva Machado; Miltom Beltrame Júnior; Maria Stella Amorin Costa Zöllner; Juliana Campos Junqueira; Antonio Olavo Cardoso Jorge
Journal:  Mycopathologia       Date:  2010-08-12       Impact factor: 2.574

Review 2.  Insights into Candida tropicalis nosocomial infections and virulence factors.

Authors:  M Negri; S Silva; M Henriques; R Oliveira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-30       Impact factor: 3.267

3.  Differential resistance to oxidants and production of hydrolytic enzymes in Candida albicans.

Authors:  Maxwel A Abegg; Rodrigo Lucietto; Paulo V G Alabarse; Marcus F A Mendes; Mara Silveira Benfato
Journal:  Mycopathologia       Date:  2010-07-15       Impact factor: 2.574

4.  Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.

Authors:  Melyssa Negri; Margarida Martins; Mariana Henriques; Terezinha I E Svidzinski; Joana Azeredo; Rosário Oliveira
Journal:  Mycopathologia       Date:  2009-10-23       Impact factor: 2.574

5.  Colonization and antifungals susceptibility patterns of Candida species isolated from hospitalized patients in ICUs and NICUs.

Authors:  Ali Zarei Mahmoudabadi; Ali Rezaei-Matehkolaei; Mojgan Navid; Mehdi Torabizadeh; Shahnam Mazdarani
Journal:  J Nephropathol       Date:  2015-07-01

6.  Extracellular enzymes and susceptibility to fluconazole in Candida strains isolated from patients with vaginitis and healthy individuals.

Authors:  Zahra Seifi; Ali Zarei Mahmoudabadi; Majid Zarrin
Journal:  Jundishapur J Microbiol       Date:  2015-03-21       Impact factor: 0.747

7.  RELATED FACTORS FOR COLONIZATION BY Candida SPECIES IN THE ORAL CAVITY OF HIV-INFECTED INDIVIDUALS.

Authors:  Ralciane de Paula Menezes; Aércio Sebastião Borges; Lúcio Borges de Araujo; Reginaldo dos Santos Pedroso; Denise Von Dolinger de Brito Röder
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Sep-Oct       Impact factor: 1.846

8.  Relationship between Antifungal Activity against Candida albicans and Electron Parameters of Selected N-Heterocyclic Thioamides.

Authors:  Jadwiga Stachowicz; Elżbieta Krajewska-Kułak; Cecylia Lukaszuk; A Niewiadomy
Journal:  Indian J Pharm Sci       Date:  2014-07       Impact factor: 0.975

Review 9.  Comprehensive biomedical applications of low temperature plasmas.

Authors:  Simone Duarte; Beatriz H D Panariello
Journal:  Arch Biochem Biophys       Date:  2020-08-26       Impact factor: 4.013

10.  Inhibitory Effect of Morin Against Candida albicans Pathogenicity and Virulence Factor Production: An in vitro and in vivo Approaches.

Authors:  Gurusamy Abirami; Rajaiah Alexpandi; Ravindran Durgadevi; Arunachalam Kannappan; Arumugam Veera Ravi
Journal:  Front Microbiol       Date:  2020-10-23       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.